ArticleHealth science reports2026
Hematological Profiles of Pulmonary Tuberculosis and Multi-Drug-Resistant Tuberculosis Patients at Debre Tabor Comprehensive Specialized Hospital, North-Central Ethiopia: A Comparative Cross-Sectional Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Tuberculosis is a major infectious disease that affects hematological profiles. However, limited data assess changes in hematological profiles among patients with pulmonary and multidrug-resistant tuberculosis. Therefore, this study aimed to compare the hematological profiles of pulmonary and multidrug-resistant tuberculosis patients at Debre Tabor Comprehensive Specialized Hospital from January 1 to May 30, 2023. Methods: An institution-based cross-sectional study was conducted on 159 study participants selected by the consecutive sampling technique. Sociodemographic and clinical data were collected through a structured questionnaire and checklist, respectively. A complete blood count was performed using an automated hematology analyzer, and a sputum sample was analyzed using the Gene Xpert MTB/RIF. The data were entered into Epi-Data software and analyzed using SPSS version 20 software. The median values of hematological parameters were compared using the Kruskal-Wallis Results: The median and interquartile ranges of red blood cell parameters (red blood cell, hemoglobin, hematocrit, mean cell volume, and mean cell hemoglobin concentration) were significantly lower in pulmonary tuberculosis patients compared to those with multidrug-resistant tuberculosis and healthy controls. In pulmonary tuberculosis patients, the magnitude of anemia and neutrophilia was 18.2% (29/159) and 9.4% (15/159), respectively. Meanwhile, eosinophilia 8.2% (13/159) and neutropenia 6.3% (10/159) were high among multidrug-resistant tuberculosis patients. Conclusion: Patients with pulmonary tuberculosis show lower red blood cell parameters, higher counts of white blood cells and neutrophils compared to multi-drug-resistant tuberculosis and healthy controls. Multi-drug-resistant tuberculosis patients also exhibit reduced red blood cells, hemoglobin, and hematocrit levels versus healthy individuals. Both pulmonary tuberculosis and multidrug-resistant tuberculosis patients displayed various hematological abnormalities like anemia, leucopenia, neutropenia, eosinophilia, and thrombocytopenia. Therefore, assessing these hematological profiles can aid in diagnosing and monitoring tuberculosis patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.